Baertsch, M. A. http://orcid.org/0000-0002-4000-6904
Lutz, R.
Raab, M. S.
Weinhold, N.
Goldschmidt, H.
Article History
Received: 9 June 2019
Accepted: 5 August 2019
First Online: 12 August 2019
Compliance with ethical standards
:
: MAB: Takeda: Consultancy; Novartis: Consultancy, Research Funding; Celgene, Amgen, Janssen: Travel grants. RL: Janssen: Travel grants. MSR: Celgene: Consultancy, Honoraria; Novartis: Consultancy, Honoraria, Research Funding; BMS: Consultancy, Honoraria, Research Funding; Amgen: Consultancy, Honoraria, Research Funding. NW: No conflict. HG: Amgen: Consultancy, Research Funding; Novartis: Honoraria, Research Funding; ArtTempi: Honoraria; Janssen: Consultancy, Honoraria, Research Funding; Sanofi: Consultancy, Research Funding; Mundipharma: Research Funding; Takeda: Consultancy, Research Funding; Celgene: Consultancy, Honoraria, Research Funding; Bristol Myers Squibb: Consultancy, Honoraria, Research Funding; Adaptive Biotechnology: Consultancy; Chugai: Honoraria, Research Funding.